Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Their drug discovery expertise has generated a pipeline of small molecule product candidates focused on indications with significant unmet patient need. The pipeline consists of eight product candidates, two of which are being pursued as core product candidates for development.